Home World News Neoadjuvant ICI Without Chemotherapy Demonstrates Potential Efficacy in Patients with Early-Stage TNBC World News Neoadjuvant ICI Without Chemotherapy Demonstrates Potential Efficacy in Patients with Early-Stage TNBC By Ogkologos - November 21, 2024 1042 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the BELLINI study Source RELATED ARTICLESMORE FROM AUTHOR Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate MOST POPULAR Longer PFS in Patients with Advanced Melanoma Treated with TILs than... December 14, 2022 New on NCI’s Websites for December 2023 December 28, 2023 ΚΑΡΚΙΝΟΣ ΣΤΟΜΑΧΟΥ February 7, 2019 Mobile Care Center Brings Breast Cancer Treatment to Amish and Mennonite... December 18, 2019 Load more HOT NEWS Combination of Enzalutamide Plus Abiraterone Acetate and Prednisone Offers No Clinical... Determining Fluid Requirements EMA Recommends Granting a Marketing Authorisation for Lutetium (177Lu) Vipivotide Tetraxetan Doctor Said Her Mammogram Results Were Normal, But Now She’s Fighting...
